Demência e COVID-19: Contributos da IV edição do Seminário Internacional Alzheimer e outras Demências

Detalhes bibliográficos
Autor(a) principal: Carreira, José
Data de Publicação: 2021
Outros Autores: Araújo, Lia, Amante, Maria João, Xavier, Paula, Fonseca, Susana
Tipo de documento: Livro
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.19/6823
Resumo: Alzheimer’s Disease International started out as the international umbrella organisation of all Alzheimers associations. It aimed to give global voice to the Alzheimers and dementia community at multilateral level (WHO, UN etc). At that time nobody advocated globally for dementia and indeed nobody knew what the prevalence and incidence figures were. As ADI continued to grow from its initial 4 members, it quickly realised that the stigma and discrimination that surrounded dementia would also need to be addressed globally and so it increased its effort to include data gathering, public policy and awareness raising. Sadly, combatting the stigma and discrimination for those living with dementia and their carers remains one of our most prominent activities to this day. Along these lines. I was grateful to attend the ‘IV International Seminar on Alzheimer's and other Dementias: Knowing, Understanding and Intervening’ to discuss the challenges of the COVID 19 pandemic for people with dementia and their caregivers. Poignantly, the COVID-19 pandemic has highlighted just how widespread ageism and discrimination is towards those living with Dementia. Many lives of older people were lost all over the world due to governments ignoring the clear and present danger the virus posed to them in a number of different and chilling ways. An example is the decision to deprioritise treatment for those having COVID-19 with dementia as an underlying condition. Shockingly in Canada, of all COVID-19 deaths in 2020, dementia or Alzheimer’s disease was reported on 36 per cent of death certificates; in Australia dementia constituted 41% of all COVID19 deaths; 26% in the UK; and 20% in regions of Italy. Many governments are still to publish their data, and, more worryingly, many are not capturing this data at all. On top of this, emerging data is also suggesting that COVID-19 may be exacerbating the dementia crisis globally: • Many people living with dementia have experienced cognitive deterioration from lack of social engagement due to social isolation, shielding, distancing and lack of social services • Many carers and people living with dementia have seen the onset of depression and anxiety as a consequence of social distancing and lack of respite and care support • More recently, we have started to look at the impact of long Covid on the brain and there is a genuine concern we may be facing more onset of dementia as a consequence of COVID-19 infection. In light of these sobering statistics, throughout the COVID-19 pandemic Alzheimer’s Disease International have continued to highlight the discrimination that has occurred globally. For those living with dementia and their carers we have developed guidance on topics such as mental health and wellbeing. On the international stage, we have continued to draw attention to these inequalities 4 through our work with the WHO and Governments around the world, maintaining pressure through coverage in the media. However, more must be done to ensure that the disproportionate impact of the COVID-19 on those living with dementia or their carers is never forgotten, nor repeated in the future. Many ask what can be done to combat the stigma and discrimination that persists. Since the launch of the World Health Organisation’s (WHO) Global action plan on the public health response to dementia 2017 – 2025, Alzheimers Disease International have advocated for the universal adoption of the recommendations set out in this plan. These seven action areas include: Dementia as a public health priority; Dementia awareness and friendliness; Dementia risk reduction; Diagnosis, treatment, care, and support; Support for dementia carers; Information systems for dementia and Dementia research and innovation. Alzheimer’s Disease International strongly believes that incorporating these seven action areas into national dementia plans is the best way to address dementia related issues in each country. Through these seminars and conferences, it is essential that we all work together to break the stigma surrounding the disease. We have created a strong momentum and a strong voice but we need to continue to press for change at every level to ensure a better life for people living with dementia and their families. Collectively, I therefore reiterate my call for the Portuguese government to show leadership by implementing a fully funded national dementia plan to support the 229,000 people living with dementia in Portugal.
id RCAP_df149d19f2c25ed3e9f8e159610374c6
oai_identifier_str oai:repositorio.ipv.pt:10400.19/6823
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Demência e COVID-19: Contributos da IV edição do Seminário Internacional Alzheimer e outras DemênciasAlzheimer’s Disease International started out as the international umbrella organisation of all Alzheimers associations. It aimed to give global voice to the Alzheimers and dementia community at multilateral level (WHO, UN etc). At that time nobody advocated globally for dementia and indeed nobody knew what the prevalence and incidence figures were. As ADI continued to grow from its initial 4 members, it quickly realised that the stigma and discrimination that surrounded dementia would also need to be addressed globally and so it increased its effort to include data gathering, public policy and awareness raising. Sadly, combatting the stigma and discrimination for those living with dementia and their carers remains one of our most prominent activities to this day. Along these lines. I was grateful to attend the ‘IV International Seminar on Alzheimer's and other Dementias: Knowing, Understanding and Intervening’ to discuss the challenges of the COVID 19 pandemic for people with dementia and their caregivers. Poignantly, the COVID-19 pandemic has highlighted just how widespread ageism and discrimination is towards those living with Dementia. Many lives of older people were lost all over the world due to governments ignoring the clear and present danger the virus posed to them in a number of different and chilling ways. An example is the decision to deprioritise treatment for those having COVID-19 with dementia as an underlying condition. Shockingly in Canada, of all COVID-19 deaths in 2020, dementia or Alzheimer’s disease was reported on 36 per cent of death certificates; in Australia dementia constituted 41% of all COVID19 deaths; 26% in the UK; and 20% in regions of Italy. Many governments are still to publish their data, and, more worryingly, many are not capturing this data at all. On top of this, emerging data is also suggesting that COVID-19 may be exacerbating the dementia crisis globally: • Many people living with dementia have experienced cognitive deterioration from lack of social engagement due to social isolation, shielding, distancing and lack of social services • Many carers and people living with dementia have seen the onset of depression and anxiety as a consequence of social distancing and lack of respite and care support • More recently, we have started to look at the impact of long Covid on the brain and there is a genuine concern we may be facing more onset of dementia as a consequence of COVID-19 infection. In light of these sobering statistics, throughout the COVID-19 pandemic Alzheimer’s Disease International have continued to highlight the discrimination that has occurred globally. For those living with dementia and their carers we have developed guidance on topics such as mental health and wellbeing. On the international stage, we have continued to draw attention to these inequalities 4 through our work with the WHO and Governments around the world, maintaining pressure through coverage in the media. However, more must be done to ensure that the disproportionate impact of the COVID-19 on those living with dementia or their carers is never forgotten, nor repeated in the future. Many ask what can be done to combat the stigma and discrimination that persists. Since the launch of the World Health Organisation’s (WHO) Global action plan on the public health response to dementia 2017 – 2025, Alzheimers Disease International have advocated for the universal adoption of the recommendations set out in this plan. These seven action areas include: Dementia as a public health priority; Dementia awareness and friendliness; Dementia risk reduction; Diagnosis, treatment, care, and support; Support for dementia carers; Information systems for dementia and Dementia research and innovation. Alzheimer’s Disease International strongly believes that incorporating these seven action areas into national dementia plans is the best way to address dementia related issues in each country. Through these seminars and conferences, it is essential that we all work together to break the stigma surrounding the disease. We have created a strong momentum and a strong voice but we need to continue to press for change at every level to ensure a better life for people living with dementia and their families. Collectively, I therefore reiterate my call for the Portuguese government to show leadership by implementing a fully funded national dementia plan to support the 229,000 people living with dementia in Portugal.Escola Superior de Educação do Instituto Politécnico de ViseuRepositório Científico do Instituto Politécnico de ViseuCarreira, JoséAraújo, LiaAmante, Maria JoãoXavier, PaulaFonseca, Susana2021-09-15T09:40:55Z2021-092021-09-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bookapplication/pdfhttp://hdl.handle.net/10400.19/6823por978-989-54743-7-0https://doi.org/10.34633/978-989-54743-7-0info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-01-16T15:29:01Zoai:repositorio.ipv.pt:10400.19/6823Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:44:40.142313Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Demência e COVID-19: Contributos da IV edição do Seminário Internacional Alzheimer e outras Demências
title Demência e COVID-19: Contributos da IV edição do Seminário Internacional Alzheimer e outras Demências
spellingShingle Demência e COVID-19: Contributos da IV edição do Seminário Internacional Alzheimer e outras Demências
Carreira, José
title_short Demência e COVID-19: Contributos da IV edição do Seminário Internacional Alzheimer e outras Demências
title_full Demência e COVID-19: Contributos da IV edição do Seminário Internacional Alzheimer e outras Demências
title_fullStr Demência e COVID-19: Contributos da IV edição do Seminário Internacional Alzheimer e outras Demências
title_full_unstemmed Demência e COVID-19: Contributos da IV edição do Seminário Internacional Alzheimer e outras Demências
title_sort Demência e COVID-19: Contributos da IV edição do Seminário Internacional Alzheimer e outras Demências
author Carreira, José
author_facet Carreira, José
Araújo, Lia
Amante, Maria João
Xavier, Paula
Fonseca, Susana
author_role author
author2 Araújo, Lia
Amante, Maria João
Xavier, Paula
Fonseca, Susana
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Politécnico de Viseu
dc.contributor.author.fl_str_mv Carreira, José
Araújo, Lia
Amante, Maria João
Xavier, Paula
Fonseca, Susana
description Alzheimer’s Disease International started out as the international umbrella organisation of all Alzheimers associations. It aimed to give global voice to the Alzheimers and dementia community at multilateral level (WHO, UN etc). At that time nobody advocated globally for dementia and indeed nobody knew what the prevalence and incidence figures were. As ADI continued to grow from its initial 4 members, it quickly realised that the stigma and discrimination that surrounded dementia would also need to be addressed globally and so it increased its effort to include data gathering, public policy and awareness raising. Sadly, combatting the stigma and discrimination for those living with dementia and their carers remains one of our most prominent activities to this day. Along these lines. I was grateful to attend the ‘IV International Seminar on Alzheimer's and other Dementias: Knowing, Understanding and Intervening’ to discuss the challenges of the COVID 19 pandemic for people with dementia and their caregivers. Poignantly, the COVID-19 pandemic has highlighted just how widespread ageism and discrimination is towards those living with Dementia. Many lives of older people were lost all over the world due to governments ignoring the clear and present danger the virus posed to them in a number of different and chilling ways. An example is the decision to deprioritise treatment for those having COVID-19 with dementia as an underlying condition. Shockingly in Canada, of all COVID-19 deaths in 2020, dementia or Alzheimer’s disease was reported on 36 per cent of death certificates; in Australia dementia constituted 41% of all COVID19 deaths; 26% in the UK; and 20% in regions of Italy. Many governments are still to publish their data, and, more worryingly, many are not capturing this data at all. On top of this, emerging data is also suggesting that COVID-19 may be exacerbating the dementia crisis globally: • Many people living with dementia have experienced cognitive deterioration from lack of social engagement due to social isolation, shielding, distancing and lack of social services • Many carers and people living with dementia have seen the onset of depression and anxiety as a consequence of social distancing and lack of respite and care support • More recently, we have started to look at the impact of long Covid on the brain and there is a genuine concern we may be facing more onset of dementia as a consequence of COVID-19 infection. In light of these sobering statistics, throughout the COVID-19 pandemic Alzheimer’s Disease International have continued to highlight the discrimination that has occurred globally. For those living with dementia and their carers we have developed guidance on topics such as mental health and wellbeing. On the international stage, we have continued to draw attention to these inequalities 4 through our work with the WHO and Governments around the world, maintaining pressure through coverage in the media. However, more must be done to ensure that the disproportionate impact of the COVID-19 on those living with dementia or their carers is never forgotten, nor repeated in the future. Many ask what can be done to combat the stigma and discrimination that persists. Since the launch of the World Health Organisation’s (WHO) Global action plan on the public health response to dementia 2017 – 2025, Alzheimers Disease International have advocated for the universal adoption of the recommendations set out in this plan. These seven action areas include: Dementia as a public health priority; Dementia awareness and friendliness; Dementia risk reduction; Diagnosis, treatment, care, and support; Support for dementia carers; Information systems for dementia and Dementia research and innovation. Alzheimer’s Disease International strongly believes that incorporating these seven action areas into national dementia plans is the best way to address dementia related issues in each country. Through these seminars and conferences, it is essential that we all work together to break the stigma surrounding the disease. We have created a strong momentum and a strong voice but we need to continue to press for change at every level to ensure a better life for people living with dementia and their families. Collectively, I therefore reiterate my call for the Portuguese government to show leadership by implementing a fully funded national dementia plan to support the 229,000 people living with dementia in Portugal.
publishDate 2021
dc.date.none.fl_str_mv 2021-09-15T09:40:55Z
2021-09
2021-09-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/book
format book
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.19/6823
url http://hdl.handle.net/10400.19/6823
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv 978-989-54743-7-0
https://doi.org/10.34633/978-989-54743-7-0
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Escola Superior de Educação do Instituto Politécnico de Viseu
publisher.none.fl_str_mv Escola Superior de Educação do Instituto Politécnico de Viseu
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130917647679488